Healthtech Startups

Move Health pairs healthcare cost intelligence technology with licensed experts to help financial advisors and households plan for healthcare expenses with greater clarity and confidence.

2 investors

CaseWorthy provides data and software solutions to health and human service organizations to improve service delivery and outcomes for vulnerable populations. The platform serves nonprofit and government agencies managing cases and support for families and individuals.

2 investors

Cast21 makes an FDA-listed, waterproof immobilization net that replaces plaster and fiberglass casts.

2 investors

Catalyst OrthoScience develops medical devices and surgical techniques for shoulder replacement procedures, including total shoulder replacements and reverse shoulder arthroplasty. The company serves orthopedic surgeons and hospitals aiming to improve patient outcomes and surgical efficiency.

2 investors

Catamaran Bio develops allogeneic CAR-NK cell therapies for cancer treatment, focusing on solid tumors, by combining natural killer (NK) cell biology with synthetic biology and non-viral cell engineering. Its proprietary TAILWIND platform is used to engineer, expand, and process NK cells into cell therapy products.

2 investors

CaTe develops technology-enabled healthcare solutions that help patients continue necessary medical care in their daily lives after hospital discharge. The company combines medical expertise with IoT, AI, and digital tools to support ongoing treatment adherence and patient monitoring, particularly for cardiac care and post-discharge recovery.

2 investors

Illumia builds technology for access control, dining, and payments used across education, healthcare, and corporate enterprise environments. Its systems support tasks such as secure building entry, nutrition-based meal ordering, and cashless purchases for the organizations it serves.

2 investors

CDL Nuclear Technologies designs and supplies cardiac PET/CT imaging equipment and services for medical facilities. The company offers flexible deployment options including custom suites, mobile units, and trailers to help cardiology practices adopt advanced diagnostic imaging technology.

2 investors

CDR-Life is a biotech company developing antibody-based therapeutics, with a focus on its proprietary platform and clinical pipeline. The page shown is an investor-relations section and provides little detail about specific programs.

2 investors

Cedargate provides a unified software platform for healthcare organizations transitioning to value-based care models, with integrated data management, analytics, decision support, and claims processing tools. The platform helps providers measure outcomes, reduce costs, and coordinate care delivery across multiple payer and patient populations.

2 investors

Celcuity is a commercial-stage biotechnology company developing targeted cancer therapies for tumors involving the PAM (PI3K/AKT/mTOR) pathway, including breast, prostate, lung, endometrial, colon, and ovarian cancers. Its lead candidate, gedatolisib, targets all Class I PI3K isoforms and the mTORC1 and mTORC2 complexes and is being evaluated across multiple oncology clinical programs.

2 investors

Celea develops deupirfenidone, a pulmonary therapeutic targeting idiopathic pulmonary fibrosis in partnership with physicians and patient advocacy organizations.

2 investors

Cell-Easy is a contract development and manufacturing organization (CDMO) specialized in process development and GMP manufacturing of cell therapies and Advanced Therapy Medicinal Products (ATMPs), including T-cells, NK cells, MSCs, and iPSCs. It serves academic laboratories, biotech, and pharma companies from early development through clinical-stage manufacturing.

2 investors

Xcelthera develops cell therapy platform technology, serving the biotech and therapeutic development sector.

2 investors

Cell BioEngines is a clinical-stage biotech company developing allogeneic "off-the-shelf" cell therapies from "super donor" stem cells, using transgene-free scalable manufacturing and HLA-guided design. It pursues stem cell-derived therapeutics across oncology and regenerative medicine.

2 investors

A software platform for home health, hospice, and personal care agencies that integrates documentation, scheduling, and billing workflows to improve care delivery and operational efficiency.

2 investors

Celltrio manufactures robotic automation systems for the life sciences industry, with patented technology for biobanking and cell culturing automation. The company licenses IP from a Korean robotics partner and develops products with a US-based engineering team.

2 investors

cellvie develops Therapeutic Mitochondria Transplantation technology and products for patients requiring mitochondrial treatment. The company combines expertise across science, regulatory affairs, manufacturing, and business to advance this therapeutic platform.

2 investors

Celsus develops artificial intelligence software for analyzing medical imaging, specifically mammograms and chest X-rays, to help radiologists detect diseases and pathologies. The solution serves healthcare providers and radiologists seeking to improve diagnostic accuracy.

2 investors

Cenacle builds a digital healthcare platform that connects hospitals and individuals, offering a cloud SaaS EMR for hospitals and a tethered PHR service for patients to access and use their own and family medical and health records. The platform aims to link healthcare partners into a connected medical ecosystem.

2 investors

Centauri Therapeutics develops the Alphamer platform, a proprietary antibody recruiting molecule technology designed to redirect the immune system against disease targets. The platform is intended for treatment of life-threatening indications across multiple disease areas.

2 investors

Center Health offers an AI health coach called Aria that syncs with continuous glucose monitors and other devices to analyze a user's glucose data and provide personalized tips on diet, sleep, exercise, and stress. It serves individuals managing diabetes, prediabetes, hypertension, and weight, as well as healthcare providers, and is available across all 50 US states.

2 investors

CenTrak provides Real-Time Location System (RTLS) technology for healthcare facilities, including IoT wearables, infrastructure devices, software, and integrations with systems like EMR, CMMS, and Nurse Call. Its solutions cover asset tracking, patient and staff safety, workflow, environmental monitoring, and patient experience across hospitals and health systems.

2 investors

Century Therapeutics develops allogeneic, iPSC-derived cell therapies using gene editing and protein engineering for autoimmune diseases including type 1 diabetes and cancer. The company aims to make cell therapies more effective, tolerable, accessible and affordable than existing treatments.

2 investors